Key takeaways
Victoza (liraglutide) and Lantus (insulin glargine) are both injectable medications used to manage diabetes, but they work in different ways and are used for different types of diabetes. Victoza is a Glucagon-like peptide-1 (GLP-1) agonist that helps your body release more insulin, stop releasing extra sugar, and slow down digestion, making it useful for Type 2 diabetes and reducing heart-related risks. On the other hand, Lantus is a long-acting insulin that helps control blood sugar levels in both Type 1 and Type 2 diabetes by providing a steady release of insulin throughout the day. Victoza is typically injected once daily and can help with weight management, while Lantus is also injected once daily but is more focused on maintaining stable blood sugar levels. Victoza can cause side effects like nausea and vomiting, whereas Lantus may lead to low blood sugar and weight gain. Additionally, Victoza is not insulin, but Lantus is a form of insulin.
